Stay updated on Ramucirumab vs Placebo in HCC Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab vs Placebo in HCC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.4%
    Check dated 2025-02-24T19:03:51.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.4%
    Check dated 2025-02-10T09:57:04.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T08:29:00.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A new study has been added regarding Ramucirumab (LY3009806) versus placebo for participants with hepatocellular carcinoma and elevated baseline alpha-fetoprotein, along with helpful links from Eli Lilly and Company.
    Difference
    0.3%
    Check dated 2025-01-27T03:33:33.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T22:14:44.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Summary
    The website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and a study link related to Ramucirumab.
    Difference
    0.3%
    Check dated 2025-01-12T17:41:12.000Z thumbnail image

Stay in the know with updates to Ramucirumab vs Placebo in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.